The Medicines Company (MDCO) financial statements (2020 and earlier)

Company profile

Business Address 8 SYLVAN WAY
PARSIPPANY, NJ 07054
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 241151542373371377
Cash and cash equivalents 238151542373371377
Short-term investments 3     
Receivables  32252156102
Inventory, net of allowances, customer advances and progress billings 1671658187
Inventory 1671658187
Disposal group, including discontinued operation  391 323  
Deferred tax assets    3314
Other undisclosed current assets 531219201613
Total current assets: 295563654833657591
Noncurrent Assets
Property, plant and equipment 91731354039
Intangible assets, net (including goodwill) 2012018719261,1791,094
Goodwill 201201256289287258
Intangible assets, net (excluding goodwill)   615636893836
Restricted cash and investments 765112
Other noncurrent assets 56112815
Deferred tax assets, net    (165)(129)
Other undisclosed noncurrent assets 32681144 165129
Total noncurrent assets: 5473101,0519741,2291,150
TOTAL ASSETS: 8428731,7051,8071,8861,741
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 58105117165223205
Accounts payable 11028362027
Accrued liabilities 589589129159142
Employee-related liabilities     4435
Interest and dividends payable     0 
Debt   54258  
Disposal group, including discontinued operation  61 68  
Business combination, contingent consideration, liability  55527210
Deferred revenue and credits41920145
Other undisclosed current liabilities     (44)(35)
Total current liabilities: 58175245537404174
Noncurrent Liabilities
Liabilities, other than long-term debt 139102103174136
Deferred tax liabilities, net  9090164129
Other liabilities 1391213108
Other undisclosed noncurrent liabilities 793664706418387538
Total noncurrent liabilities: 806673808521562675
Total liabilities: 8648481,0521,058966849
Temporary equity, carrying amount   117  
Stockholders' equity
Stockholders' equity attributable to parent (22)25653732921892
Common stock 000000
Treasury stock, value (90)(90)(50)(50)(50)(50)
Additional paid in capital 1,4531,3771,2571,2081,045992
Accumulated other comprehensive income (loss) (5)(5)(5)43(5)
Accumulated deficit (1,381)(1,257)(549)(430)(77)(45)
Stockholders' equity attributable to noncontrolling interest   (1)(0)(0)(0)
Total stockholders' equity: (22)25652732920892
TOTAL LIABILITIES AND EQUITY: 8428731,7051,8071,8861,741

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 64516830915
Revenue, net45168309724688
Cost of revenue (36)(47)(333)(120)(288)(263)
Cost of goods and services sold (7)(47)(71)(120)(288)(263)
Gross profit: (30)(2)(165)189(286)(258)
Operating expenses (162)(663)(196)(462)(537)(448)
Other undisclosed operating income     759719
Operating income (loss): (191)(665)(362)(272)(65)13
Nonoperating income (expense) (46)200(6)1
Investment income, nonoperating (52)   (8)(0)
Other nonoperating income 620002
Interest and debt expense (49)(49)(50)(37)(16)(16)
Other undisclosed income from continuing operations before equity method investments, income taxes     4718
Income (loss) from continuing operations before equity method investments, income taxes: (287)(712)(411)(309)(39)17
Loss from equity method investments    (0)(2)(1)
Other undisclosed income from continuing operations before income taxes 1829258  
Income (loss) from continuing operations before income taxes: (286)(704)(119)(252)(41)15
Income tax expense (benefit) 5197(0)307(1)
Other undisclosed income (loss) from continuing operations     (5)3
Income (loss) from continuing operations: (235)(608)(119)(222)(39)17
Income (loss) from discontinued operations  (101)0   
Income (loss) before gain (loss) on sale of properties: (235)(708)(119)(222)(39)17
Other undisclosed net income (loss) 112  (131)7(1)
Net income (loss): (123)(708)(119)(353)(32)16
Net income attributable to noncontrolling interest   0 00
Other undisclosed net loss attributable to parent    (0)(0)(1)
Net income (loss) available to common stockholders, diluted: (123)(708)(119)(353)(32)15

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss): (123)(708)(119)(353)(32)16
Other comprehensive income (loss) 10(9)17(4)
Comprehensive income (loss): (123)(708)(129)(351)(25)12
Comprehensive income (loss), net of tax, attributable to noncontrolling interest   0(0)0(0)
Other undisclosed comprehensive loss, net of tax, attributable to parent     (0) 
Comprehensive income (loss), net of tax, attributable to parent: (123)(708)(129)(351)(25)11

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: